4.7 Article

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome

Luis Veloza et al.

Summary: Monomorphic epitheliotropic intestinal T-cell lymphoma (MEITL) is a rare aggressive T-cell lymphoma, commonly seen in Asia. This study investigated 71 European MEITL patients and found that the majority of patients presented with gastrointestinal involvement and had emergency surgery. The tumors were morphologically classified into typical and atypical groups, with a homogeneous immunophenotypic profile. MYC expression and TP53 mutation were correlated with atypical morphology and poor outcome, while aberrant B-cell marker expression correlated with better survival. MEITL is an aggressive disease with high clinical risk.

HAEMATOLOGICA (2023)

Article Hematology

Genetic and phenotypic attributes of splenic marginal zone lymphoma

Ferdinando Bonfiglio et al.

Summary: Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity with different subgroups characterized by genetic abnormalities, pathway signatures, and microenvironment compositions. These findings provide insights into the classification and treatment of SMZL.
Review Hematology

Genetic and epigenetic insights into cutaneous T-cell lymphoma

Cornelis P. Tensen et al.

Summary: Significant progress has been made in understanding the pathogenesis of CTCLs in recent years, thanks to advancements in CTCL classifications and technical innovations. These studies have revealed extensive heterogeneity between different CTCL subtypes and identified recurrent alterations that are highly characteristic for specific diagnostic subgroups. These findings have potential implications for the development of targeted therapeutic strategies.
Article Hematology

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

Paul G. Kemps et al.

Summary: ALK-positive histiocytosis is a rare and poorly characterized subtype of histiocytic neoplasm. This study provides the largest analysis of ALK-positive histiocytosis to date, describing the clinicopathologic and molecular characteristics of 39 cases. The study also highlights the robust responses observed in patients treated with ALK inhibition, particularly those with neurologic involvement.
Article Hematology

Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Cho Mar Myint Wai et al.

Summary: Primary EBV-positive nodal T/NK-cell lymphoma is a distinct entity characterized by low genomic instability, upregulation of immune pathways, and downregulation of EBV miRNA expression.

HAEMATOLOGICA (2022)

Article Hematology

Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing

Axel Kuenstner et al.

Summary: This study investigates the mutational landscape of high-grade B-cell lymphoma accompanied with double/triple-hit MYC and BCL2 and/or BCL6 rearrangements (HGBLDH/TH). The study finds oncogenic mutations in several signaling pathways and reveals the mutational relationship between several types of lymphomas. Additionally, the study uncovers molecular divergence between BCL2 and BCL6 rearranged HGBL-DH cases.

HAEMATOLOGICA (2022)

Article Hematology

Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression/transformation

Karoline Koch et al.

Summary: The sole distinguishing feature between follicular lymphoma grade 3B and diffuse large B-cell lymphoma is the growth pattern assessed by histopathology. However, the clinical relevance of this finding when occurring in follicular lymphoma grade 3B is uncertain. To address this issue, the immunophenotype and molecular genetic features of individual and coexisting follicular lymphoma grade 3B and diffuse large B-cell lymphoma were analyzed. The results showed that they have distinct gene expression features reflecting a divergent microenvironment but do not differ significantly for major clinical parameters.

HAEMATOLOGICA (2022)

Article Pathology

Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge

Mahsa Khanlari et al.

Summary: The study demonstrated significant differences in immunophenotypic, cytogenetic, and molecular features between blastoid-HGBL and B-ALL. The scoring system developed based on distinctive features showed high sensitivity and specificity for the classification of blastoid lymphoid tumors presenting initially in the bone marrow.

MODERN PATHOLOGY (2022)

Article Gastroenterology & Hepatology

Oncogenetic landscape of lymphomagenesis in coeliac disease

Sascha Cording et al.

Summary: The study identified mutations activating the JAK1-STAT3 pathway as the main drivers of enteropathy-associated T-cell lymphoma, potentially in combination with mutations in negative regulators of NF-kappa B. These mutations could promote the clonal emergence of malignant lymphocytes in the cytokine-rich coeliac intestine, and are attractive therapeutic targets for treating refractory celiac disease and blocking progression towards EATL.
Article Pathology

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas

Anne M. R. Schrader et al.

Summary: This study compared the COO classification of two different types of primary cutaneous B-cell lymphoma (PCDLBCL-LT and PCFCL-LC) and found that their classification results were different. PCFCL-LC was almost always classified as the GCB subtype, while the classification of PCDLBCL-LT was more heterogeneous. However, these different classification results were not associated with the expression of BCL2 and IgM, gene mutations, gene loss, or patient survival.

VIRCHOWS ARCHIV (2022)

Article Pathology

Mutational Landscape of TdT+ Large B-cell Lymphomas Supports Their Distinction From B-lymphoblastic Neoplasms A Multiparameter Study of a Rare and Aggressive Entity

Shweta Bhavsar et al.

Summary: In the current classification of the World Health Organization, TdT expression in high grade/large cell B-cell lymphoma indicates B-lymphoblastic lymphoma/leukemia. However, there are reports of TdT expression in mature LBCL or following mature B-cell neoplasms. The frequency, categorization, clinicopathologic features, molecular landscape, and relationship to classic B-LBL of TdT(+) LBCL remain to be better defined. In this study, TdT expression was assessed in 258 LBCL and correlated with cytologic, phenotypic, and cytogenetic findings. Mutational analysis, review of prior biopsies, and assessment of clinical associations were performed in 6 cases with >10% TdT(+) cells. The 6 TdT(+) LBCL cases were blastoid-appearing, CD34(-), MYC+, BCL2(+), and had MYC rearrangements (R) (5/6 with BCL2 and/or BCL6-R). They had a prior TdT(-) LBCL and/or follicular lymphoma and all had an aggressive course. The mutational profiles were more like those reported in germinal center B-cell type-diffuse LBCL rather than B-LBL. The clinicopathologic and cytogenetic features of these 6 cases were similar to those found in a meta-analysis that included additional cases of TdT(+) LBCL or B-LBL following follicular lymphoma. Thus, TdT(+), CD34(-) large B-cell neoplasms with MYC rearrangements and often a double hit are rare, frequently a transformational event and aggressive but are distinct from classic B-LBL.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2022)

Review Hematology

KSHV/HHV8-mediated hematologic diseases

Ethel Cesarman et al.

Summary: Kaposi sarcoma herpesvirus (KSHV), also known as human herpesvirus 8, is associated with various lymphoproliferative disorders. KSHV and Epstein-Barr virus (EBV) can infect and transform the same B cell, potentially leading to different diseases. Understanding KSHV biology and clinical features is crucial for targeted therapeutic interventions.
Review Hematology

Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?

Ryan D. Morin et al.

Summary: The term DLBCL encompasses a diverse collection of tumors, and recent molecular profiling studies have proposed new classification systems to overcome this biological heterogeneity. Challenges include applying these new systems in clinical practice, introducing genomic subtyping and precision medicine into DLBCL, and addressing the implications for current clinical practices and trials.

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Article Dermatology

IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression

Eric D. Carlsen et al.

Summary: This study found that some PCMZL expressed IRTA1, supporting the concept of MALT-lymphoma-like PCMZL, but class-switched subtype also showed IRTA1 expression. The conclusion emphasizes that the distinction of PCMZL subtypes should be based on more factors rather than just heavy chain expression.

JOURNAL OF CUTANEOUS PATHOLOGY (2022)

Article Pathology

Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations

Alina Nicolae et al.

Summary: This study examined the clinicopathological and molecular characteristics of nodal peripheral T-cell lymphoma, not otherwise specified (PTCL, NOS) with cytotoxic phenotype in Western patients. The findings revealed that this rare disease in the Western population is associated with aggressive behavior and impaired immunity.

MODERN PATHOLOGY (2022)

Article Hematology

A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

Julia Salmeron-Villalobos et al.

Summary: Pediatric nodal marginal zone lymphoma (PNMZL) is a rare B-cell neoplasm mainly affecting male children and young adults. It has overlapping clinical, morphological, and molecular features with pediatric-type follicular lymphoma (PTFL).

BLOOD ADVANCES (2022)

Article Hematology

International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

Daniel A. Arber et al.

Summary: In 2016, the WHO, Society for Hematopathology, and European Association for Haematopathology collaborated to update the classification of myeloid neoplasms and acute leukemias, advancing the field of myeloid neoplasms and acute leukemias.
Article Hematology

MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma

Lifu Wang et al.

Summary: Mantle cell lymphoma (MCL) with MYC rearrangement (MYC-R) is rare and has shown to be a negative prognostic factor for patients. Patients with MYC-EC have an intermediate overall survival compared to MYC-R and MYC-NL patients, especially those with blastoid/pleomorphic morphology.

HAEMATOLOGICA (2021)

Article Hematology

Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma

Naoki Oishi et al.

Summary: BIA-ALCL is characterized as a hypoxia-associated neoplasm with significant upregulation of CA9 gene expression. These findings support the classification of BIA-ALCL as a distinct entity and reveal the potential of hypoxia-related proteins like CA9 as novel biomarkers and therapeutic targets in this disease.

HAEMATOLOGICA (2021)

Article Dermatology

A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse large B-cell lymphoma with immature features or B-cell lymphoblastic lymphoma?

Andrea Ronchi et al.

Summary: Primary cutaneous B-cell lymphomas are a diverse group of lymphoid neoplasms mainly found in the skin, with primary cutaneous follicle center cell lymphoma being the most common. These cases often exhibit histopathologic and immunohistochemical features, but in some instances, immature cell lymphomas may present, posing a diagnostic challenge.

JOURNAL OF CUTANEOUS PATHOLOGY (2021)

Article Hematology

Mutational landscape of gray zone lymphoma

Clementine Sarkozy et al.

Summary: The mutational landscape of gray zone lymphoma (GZL) differs between cases with and without thymic niche involvement, showing distinct patterns related to apoptosis defects and BCL2/BCL6 rearrangements, respectively. Additionally, poly-EBV-L cases exhibit a unique mutational profile with STAT3 mutations and lower coding mutation load compared to EBV- GZL. These findings suggest common cell of origin and disease evolution among GZL with thymic presentation and related anterior mediastinal lymphomas.
Article Pathology

Lymph node involvement by enteropathy-like indolent NK-cell proliferation

Jean-Louis Dargent et al.

Summary: NKCE and LG are closely related lymphoproliferative disorders composed of mature and EBV-negative NK cells, mainly arising within the gastrointestinal tract but occasionally involving other sites. This case report describes a unique lymph node infiltration by such EBV-negative NK cell proliferation, exhibiting similar features to NKCE or LG, suggesting occasional lymph node involvement by similar indolent EBV-negative NK cell LPDs.

VIRCHOWS ARCHIV (2021)

Article Pathology

New Clinicopathologic Scenarios of EBV+ Inflammatory Follicular Dendritic Cell Sarcoma Report of 9 Extrahepatosplenic Cases

Xiang-Nan Jiang et al.

Summary: EBV-positive inflammatory FDC sarcoma is a rare malignant neoplasm that occurs mainly in extrahepatosplenic anatomical sites, with an association with Epstein-Barr virus. These tumors typically occur near the aerodigestive tract and exhibit consistent histological features under the microscope. The patients have a median age of 58 years, with a female predominance over males.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Hematology

IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics

Ferran Nadeu et al.

Summary: The B-cell receptor (BCR) signaling is crucial for chronic lymphocytic leukemia (CLL) biology, with IGLV3-21-expressing B cells potentially acquiring a single point mutation (R110) triggering autonomous BCR signaling. Epigenetic studies have identified 3 CLL subtypes, with IGLV3-21(R110) CLL defining a subgroup with specific biological features and an unfavorable prognosis independent of IGHV mutational status and epigenetic subtype.
Article Hematology

Frequent genetic alterations in immune checkpoint-related genes in intravascular large B-cell lymphoma

Kazuyuki Shimada et al.

Summary: IVLBCL is a unique type of extranodal lymphoma characterized by selective growth of tumor cells in small vessels without lymphadenopathy. Whole-exome sequencing revealed genetic features of activated B-cell-type DLBCL in IVLBCL, and identified rearrangements of PD-L1/PD-L2 and immune evasion mechanisms as potential therapeutic targets.
Article Oncology

Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL

Wyndham H. Wilson et al.

Summary: In younger patients with non-GCB DLBCL, the addition of ibrutinib to R-CHOP chemotherapy improves survival rates, particularly in patients with MCD and N1 subtypes. This study provides mechanistic understanding of the benefit of ibrutinib in this patient population.

CANCER CELL (2021)

Review Oncology

CXCR4 in Waldenstrom's Macroglobulinema: chances and challenges

Lisa Marie Kaiser et al.

Summary: WM is an incurable B-cell neoplasm characterized by mutations in MYD88 and CXCR4 genes. Understanding the molecular landscape of WM has paved the way for predicting treatment response to drugs like ibrutinib and developing novel therapeutic approaches. The role of CXCR4 in WM biology, prognostic and predictive relevance, and therapeutic implications have been highlighted in recent research.

LEUKEMIA (2021)

Article Oncology

Clinical characteristics and outcomes of primary versus secondary gastrointestinal mantle cell lymphoma

Alessia Castellino et al.

Summary: Primary GI MCL is rare but has similar outcomes as secondary GI MCL. Less aggressive frontline treatment is reasonable for primary GI MCL, with the impact of GI involvement on treatment selection but not on outcome. It remains uncertain whether more aggressive treatment can lead to improved outcomes.

BLOOD CANCER JOURNAL (2021)

Review Hematology

The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma

Allison Barraclough et al.

Summary: Grade 3B follicular lymphoma is rare and often excluded from clinical trials, leading to conflicting data on diagnosis, outcomes, therapy choices, and imaging role. New research is exploring unique genetic characteristics, PET imaging features, therapy choices, and outcomes in the current era, highlighting the importance of characterization and treatment of G3B FL.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Article Oncology

Addition of Lenalidomide to R-CHOP Improves Outcomes in Newly Diagnosed Diffuse Large B-Cell Lymphoma in a Randomized Phase II US Intergroup Study ECOG-ACRIN E1412

Grzegorz S. Nowakowski et al.

Summary: The addition of lenalidomide to R-CHOP (R2CHOP) in newly diagnosed DLBCL, particularly in the ABC-DLBCL subtype, showed improved outcomes including better progression-free survival and overall survival rates. This study suggests that R2CHOP may be an effective treatment option for patients with DLBCL, especially those with the ABC-DLBCL subtype.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma

Grzegorz S. Nowakowski et al.

Summary: The ROBUST study aimed to compare the efficacy of lenalidomide plus R-CHOP with placebo/R-CHOP in previously untreated ABC-type DLBCL. While the primary end point of progression-free survival (PFS) was not met in all patients, there were trends favoring R2-CHOP over placebo/R-CHOP in patients with higher-risk disease. The safety profile of R2-CHOP was consistent with individual treatments with no new safety signals.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Pathology

Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features

Sietse M. Aukema et al.

Summary: Chromosomal breakpoints involving the MYC gene locus are common in B-cell lymphomas, associated with aggressive clinical course, while MYC rearrangements are rare in MCL. The MYC rearranged MCL cases in this study showed features such as high genomic-complexity, deletions involving the CDKN2A locus, high Ki-67 proliferation index, and frequent P53 expression.

VIRCHOWS ARCHIV (2021)

Article Pathology

The Burkitt-like immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS

Katrin S. Huettl et al.

Summary: Burkitt lymphoma is characterized by a specific immunophenotype and genetic features, typically requiring intensified chemotherapy. Despite morphologic overlap with other high-grade B cell lymphomas, the combination of CD10+, BCL6+, BCL2- and MYCR positive immunophenotype is relatively rare.

VIRCHOWS ARCHIV (2021)

Article Hematology

Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features

Xiaolong Alan Zhou et al.

Summary: PCFCL is a unique entity with distinct biological features, usually restricted to the skin and different from usual systemic FL and SCFL.

BLOOD ADVANCES (2021)

Article Medical Laboratory Technology

A Tissue Counterpart to Monoclonal B-Cell Lymphocytosis Clinical and Pathologic Features

Gabriel K. Habermehl et al.

Summary: The study characterized tissue counterpart to peripheral blood monoclonal B-cell lymphocytosis (tMBL) and found that it spans an immunophenotypic spectrum similar to MBL. Detectable by immunohistochemistry in some cases, the progression to overt lymphoma is uncommon but may occur, necessitating clinical follow-up.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)

Article Hematology

Combined oral 5-azacytidine and romidepsin are highly effective in patients with PTCL: a multicenter phase 2 study

Lorenzo Falchi et al.

Summary: The combination of histone deacetylase inhibitors and DNA methyltransferase inhibitors showed high activity and safety in patients with PTCL, with particularly good outcomes in tTFH phenotype patients. This combination could potentially serve as a platform for novel regimens in the treatment of PTCL.
Article Pathology

Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma

Shweta Chaudhary et al.

Summary: MYC rearrangement is relatively rare in follicular lymphoma (FL). Cases with MYC rearrangement in FL do not have specific histologic characteristics, but show abnormalities in genes associated with transformation, particularly MYC and B2M. Larger studies are needed to determine the prognostic significance of MYC rearrangement in FL.

HUMAN PATHOLOGY (2021)

Review Medicine, General & Internal

Histiocytosis

Jean-Francois Emile et al.

Summary: Histiocytoses are rare disorders characterized by infiltration of various organs by myeloid cells, with diagnosis often delayed due to low incidence and diverse clinical manifestations. Somatic mutations in genes activating the MAP kinase pathway are commonly found in biopsy specimens, and targeted therapies with BRAF or MEK inhibitors have revolutionized treatment but challenges such as duration and prevention of neurological sequelae remain.

LANCET (2021)

Article Hematology

Peripheral T-cell lymphoma: molecular profiling recognizes subclasses and identifies prognostic markers

Marta Rodriguez et al.

Summary: This study analyzed cases of Peripheral T-cell lymphoma (PTCL) to identify specific gene sets associated with different histological types, supporting the division of PTCL into 3 categories and identifying B-cell gene expression as an independent prognostic factor for AITL. The study also highlighted the importance of mutational profiles, with differences in RHOA mutations among the PTCL classes.

BLOOD ADVANCES (2021)

Review Medicine, General & Internal

Monoclonal Gammopathy of Renal Significance

Nelson Leung et al.

Summary: Monoclonal gammopathy of renal significance is a non-cancerous clonal disorder that produces monoclonal immunoglobulin leading to kidney injury or disease. It is discussed in terms of pathogenesis, evaluation, and management.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pathology

High-grade Follicular Lymphomas Exhibit Clinicopathologic, Cytogenetic, and Molecular Diversity Extending Beyond Grades 3A and 3B

Camille Laurent et al.

Summary: This study investigated the clinicopathologic diversity of grade 3 follicular lymphoma (FL3) and found that some cases did not strictly fit WHO criteria for either FL3A or FL3B, being classified as unconventional high-grade FL (FL3U). FL3U cases displayed worse outcomes compared to FL1-2 patients, suggesting that high-grade FLs encompass a heterogeneous spectrum of tumors with variable morphology and genomic alterations. The distinction of FL3U may be useful for a better comprehension of high-grade FLs and for designing clinical trials.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Hematology

Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies

Lucile Bussot et al.

Summary: MYC-EC has no prognostic impact on FL in terms of disease progression and patient survival, while MYC-R FL may be associated with increased risk of transformation and poorer outcomes.

BRITISH JOURNAL OF HAEMATOLOGY (2021)

Article Oncology

TP53 Mutations with Low Variant Allele Frequency Predict Short Survival in Chronic Lymphocytic Leukemia

Riccardo Bomben et al.

Summary: This study retrospectively analyzed the clinical impact of TP53 mutations in chronic lymphocytic leukemia, finding that TP53 mutations affect overall survival regardless of variant allele frequency. The results of the study suggest updating the definition of TP53 mutated CLL for clinical purposes.

CLINICAL CANCER RESEARCH (2021)

Article Pathology

Detection of Gene Fusion Transcripts in Peripheral T-Cell Lymphoma Using a Multiplexed Targeted Sequencing Assay

Fanny Drieux et al.

Summary: This study developed a multiplex ligation-dependent RT-PCR-based assay to detect 33 known PTCL-associated fusion transcripts, providing an efficient tool for identifying genetic variations in PTCL. The research found that in 239 different types of PTCL, in addition to ALK fusion transcripts, there are various non-ALK fusion transcripts, with ICOS_CD28 being the most common.

JOURNAL OF MOLECULAR DIAGNOSTICS (2021)

Review Oncology

CD5+diffuse large B-cell lymphoma: a narrative review

Urshila Durani et al.

Summary: CD5+ DLBCL is a rare subset associated with increased age, high lactate dehydrogenase, B symptoms, extra-nodal sites, higher International Prognostic Index score, and advanced stage in some studies. It is more likely to express Bcl-2, MYC, and MUM1, with a large proportion exhibiting an activated B-cell (ABC)-like phenotype. Studies generally support an independent prognostic value of CD5 in DLBCL, although evidence for more aggressive treatment approaches for CD5+ DLBCL is lacking.

LEUKEMIA & LYMPHOMA (2021)

Article Hematology

Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations

Jiwon Koh et al.

Summary: The HAVCR2(Y82C) mutation is common in Korean SPTCL patients and is associated with unique clinicopathological and genetic features. Combining clinical and histopathological parameters can help predict prognosis for SPTCL patients.

BLOOD ADVANCES (2021)

Article Hematology

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma

Niklas Gebauer et al.

Summary: A recent discovery of Burkitt-like lymphoma with 11q aberration (BLL-11q) suggests that 11q abnormalities can be found in both BLL in the context of an underlying HIV infection and in high-grade B-cell lymphomas with MYC, BCL2, and/or BCL6 rearrangements. This indicates that the clinicopathological spectrum of malignancies carrying this aberration may be broader than previously assumed.

BLOOD ADVANCES (2021)

Article Hematology

Clinicopathological features and survival in EBV-positive diffuse large B-cell lymphoma not otherwise specified

Estelle Bourbon et al.

Summary: This retrospective study reported 70 cases of EBV(+) diffuse large B-cell lymphoma, with a median age of 68.5 years. Patients were mainly treated with immunochemotherapy or chemotherapy. Older age and HLH were associated with shorter PFS and OS.

BLOOD ADVANCES (2021)

Article Pathology

A Diagnostic Approach to the Identification of Burkitt-like Lymphoma With 11q Aberration in Aggressive B-Cell Lymphomas

Heike Horn et al.

Summary: Analysis of 11q status is recommended for MYC-negative high-grade lymphomas with features of Burkitt lymphoma, especially showing BCL2 negativity and a conspicuous coarse apoptotic debris in starry sky macrophages.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Pathology

Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy

Aliyah R. Sohani et al.

Summary: Research on follicular lymphoma suggests that prognosis risk can be influenced by various factors and stratification of risk is possible through specific biomarkers. Further validation of these findings may provide insights into improving prognosis prediction for patients.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2021)

Article Hematology

Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

Joan Enric Ramis-Zaldivar et al.

Review Pathology

Double-Hit and Triple-Hit Follicular Lymphoma Case Series and Review of 40 Cases

Jessica B. Ziemba et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Article Multidisciplinary Sciences

IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling

Palash C. Maity et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Pathology

Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders

Fanny Beltzung et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)

Review Pathology

How I Diagnose Primary Cutaneous Marginal Zone Lymphoma

Sarah E. Gibson et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2020)

Review Clinical Neurology

Primary Central Nervous System Lymphomatoid Granulomatosis: Systemic Review

Yuanyuan Xiang et al.

FRONTIERS IN NEUROLOGY (2020)

Editorial Material Hematology

Chromosomes in breast lymphoma

Laurence de Leval

Review Hematology

Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification

Seiichi Kato et al.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY (2020)

Letter Hematology

Identification of high-risk DUSP22-rearranged ALK-negative anaplastic large cell lymphoma

Greg Hapgood et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Article Multidisciplinary Sciences

Efficacy of MEK inhibition in patients with histiocytic neoplasms

Eli L. Diamond et al.

NATURE (2019)

Letter Hematology

Recurrent somatic JAK3 mutations in NK-cell enteropathy

Wenbin Xiao et al.

Letter Hematology

Primary cutaneous acral CD8+ T-cell lymphomas relapse more frequently in younger patients

Eve Maubec et al.

BRITISH JOURNAL OF HAEMATOLOGY (2019)

Article Dermatology

Double-positive CD8/CD4 primary cutaneous acral T-cell lymphoma

Ferdinand Toberer et al.

JOURNAL OF CUTANEOUS PATHOLOGY (2019)

Article Pathology

SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients

Jie Xu et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Article Pathology

SYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma

Grit Mutzbauer et al.

MODERN PATHOLOGY (2018)

Review Hematology

How I treat T-cell chronic active Epstein-Barr virus disease

Catherine M. Bollard et al.

Letter Hematology

Liquid biopsy for the identification of intravascular large B-cell lymphoma

Yasuhito Suehara et al.

HAEMATOLOGICA (2018)

Article Dermatology

Panel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma

Katja Maurus et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)

Article Biochemistry & Molecular Biology

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia

Renee Beekman et al.

NATURE MEDICINE (2018)

Article Medicine, General & Internal

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

R. Schmitz et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Letter Hematology

Liquid biopsy for the identification of intravascular large B-cell lymphoma

Yasuhito Suehara et al.

HAEMATOLOGICA (2018)

Article Biochemistry & Molecular Biology

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

Guy Ledergor et al.

NATURE MEDICINE (2018)

Letter Hematology

Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease

Agnieszka Malecka et al.

BRITISH JOURNAL OF HAEMATOLOGY (2018)

Review Oncology

Antigen receptor stereotypy in chronic lymphocytic leukemia

K. Stamatopoulos et al.

LEUKEMIA (2017)

Review Oncology

Genomic complexity of multiple myeloma and its clinical implications

Salomon Manier et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Immunology

Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2

Andrea B. Moffitt et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2017)

Article Medicine, General & Internal

Presentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis: The Mayo Clinic Experience

Taxiarchis V. Kourelis et al.

MAYO CLINIC PROCEEDINGS (2017)

Article Multidisciplinary Sciences

Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing

L. Rasche et al.

NATURE COMMUNICATIONS (2017)

Review Immunology

Chronic Active Epstein-Barr Virus Disease

Hiroshi Kimura et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Oncology

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

Moaath Mustafa Ali et al.

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2017)

Review Oncology

Evolutionary biology of high-risk multiple myeloma

Charlotte Pawlyn et al.

NATURE REVIEWS CANCER (2017)

Article Pathology

Mantle Cell Lymphoma With MYC Rearrangement A Report of 17 Patients

Zhihong Hu et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2017)

Review Pathology

EBV-Positive B-Cell Proliferations of Varied Malignant Potential 2015 SH/EAHP Workshop Report-Part 1

Yasodha Natkunam et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2017)

Article Hematology

Clonal architecture of CXCR4 WHIM-like mutations in Waldenstrom Macroglobulinaemia

Lian Xu et al.

BRITISH JOURNAL OF HAEMATOLOGY (2016)

Article Clinical Neurology

Recurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas

T. Nakamura et al.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)

Review Pathology

Mantle cell lymphoma-a spectrum from indolent to aggressive disease

Birgitta Sander et al.

VIRCHOWS ARCHIV (2016)

Article Pathology

Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma

Kohei Taniguchi et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2016)

Article Multidisciplinary Sciences

Non-coding recurrent mutations in chronic lymphocytic leukaemia

Xose S. Puente et al.

NATURE (2015)

Article Multidisciplinary Sciences

Mutations driving CLL and their evolution in progression and relapse

Dan A. Landau et al.

NATURE (2015)

Article Multidisciplinary Sciences

Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells

Can Kucuk et al.

NATURE COMMUNICATIONS (2015)

Article Pathology

Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements

Rebecca L. King et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)

Article Dermatology

Hydroa Vacciniforme–Like Lymphoma With Primarily Periorbital Swelling

Jose A. Plaza et al.

AMERICAN JOURNAL OF DERMATOPATHOLOGY (2014)

Article Hematology

A prospective study of mediastinal gray-zone lymphoma

Wyndham H. Wilson et al.

Editorial Material Hematology

Cellular origin of T-cell lymphomas

Laurence de Leval et al.

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Conjunctival MALT Lymphoma Utility of FDG PET/CT for Diagnosis, Staging, and Evaluation of Treatment Response

Asmaa Sallak et al.

CLINICAL NUCLEAR MEDICINE (2014)

Article Pathology

KSHV/HHV8-negative Effusion-based Lymphoma, a Distinct Entity Associated With Fluid Overload States

Serge Alexanian et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Letter Hematology

Diagnosis of type II enteropathy-associated T-cell lymphoma should be limited to EBER- cases

Soo-Yong Tan et al.

AMERICAN JOURNAL OF HEMATOLOGY (2012)

Article Oncology

Primary Follicular Lymphoma of the Testis in Children and Adolescents

Mark A. Lones et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2012)

Article Pathology

Current histological diagnosis of lymphomatoid granulomatosis

Thomas V. Colby

MODERN PATHOLOGY (2012)

Article Medicine, General & Internal

MYD88 L265P Somatic Mutation in Waldenstrom's Macroglobulinemia

Steven P. Treon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Hematology

Reassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis

Sarah E. Gibson et al.

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)

Article Cell Biology

Epstein-Barr virus-positive systemic NK/T-cell lymphomas in children: report of six cases

Socorro M. Rodriguez-Pinilla et al.

HISTOPATHOLOGY (2011)

Article Pathology

Cutaneous Marginal Zone Lymphomas Have Distinctive Features and Include 2 Subsets

James T. Edinger et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)

Article Pathology

EBV Positive Mucocutaneous Ulcer-A Study of 26 Cases Associated With Various Sources of Immunosuppression

Stefan D. Dojcinov et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2010)

Article Hematology

The molecular classification of multiple myeloma

Fenghuang Zhan et al.

Review Oncology

Molecular pathogenesis and a consequent classification of multiple myeloma

PL Bergsagel et al.

JOURNAL OF CLINICAL ONCOLOGY (2005)

Article Multidisciplinary Sciences

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

G Wright et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Medicine, General & Internal

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

A Rosenwald et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)